BioCentury
ARTICLE | Finance

Immuneering, Terns, Ikena raise crossover rounds as IPO queue stands to grow again

January 5, 2021 12:12 PM UTC

With crossover investors lining up to participate, biotechs Immuneering, Terns and Ikena each raised rounds that could augur upcoming public offerings.

The deals come as a host of biotechs will likely seek to test the public markets, continuing a trend after a record-setting year for NASDAQ listings in 2020...